LETTER
Synthesis of Arylated Pyrazoles
1925
(4) For a review of cyclization reactions of dianions in organic
synthesis, see: (a) Langer, P.; Freiberg, W. Chem. Rev.
2004, 104, 4125. For original papers, see: (b) Matsumura,
N.; Kunigihara, A.; Yoneda, S. Tetrahedron Lett. 1983, 24,
3239. (c) Matsumura, N.; Kunigihara, A.; Yoneda, S.
Tetrahedron Lett. 1984, 25, 4529. (d) Duncan, D. C.;
Trumbo, T. A.; Almquist, C. D.; Lentz, T. A.; Beam, C. F.
J. Heterocycl. Chem. 1987, 24, 555. (e) Beam, C. F.;
Reames, D. C.; Harris, C. E.; Dasher, I. W.; Hollinger,
W. M.; Shealy, N. L.; Sandifer, R. M.; Perkins, M.; Hauser,
C. R. J. Org. Chem. 1975, 40, 514. (f) Persson, T.; Nielsen,
J. Org. Lett. 2006, 8, 3219. (g) Dang, T. T.; Dang, T. T.;
Reinke, H.; Fischer, C.; Langer, P. Tetrahedron 2008, 64,
2207.
(5) Ranatunge, R. R.; Augustyniak, M.; Bandarage, U. K.; Earl,
R. A.; Ellis, J. L.; Garvey, D. S.; Janero, D. R.; Letts, L. G.;
Martino, A. M.; Murty, M. G.; Richardson, S. K.; Schroeder,
J. D.; Shumway, M. J.; Tam, S. W.; Trocha, A. M.; Young,
D. V. J. Med. Chem. 2004, 47, 2180.
(6) For reviews of cross-coupling reactions of polyhalogenated
heterocycles, see: (a) Schröter, S.; Stock, C.; Bach, T.
Tetrahedron 2005, 61, 2245. (b) Schnürch, M.; Flasik, R.;
Khan, A. F.; Spina, M.; Mihovilovic, M. D.; Stanetty, P. Eur.
J. Org. Chem. 2006, 3283.
Br
Ar
ArB(OH)2
3a, e–j
Br
Ar
Br
Ar
i
N
N
N
N
R
2a,b
R
6a–g
.
Scheme 4 Synthesis of 3,4,5-triarylpyrazoles 6a–g. Reagents and
conditions: (i) 2a,b (1.0 equiv), ArB(OH)2 (3.5 equiv), K3PO4 (4.5
equiv), Pd(PPh3)4 (10 mol%), 1,4-dioxane–H2O (4:1), 100 °C, 12 h.
Table 3 Synthesis of 6a–g
2
3
6
R
Ar
Yield of 6
(%)a
a
a
b
b
b
b
a
a
e
f
a
b
c
d
e
f
Bn
4-MeC6H4
4-FC6H4
70
63
57
76
72
74
50
Bn
vinyl
vinyl
vinyl
vinyl
Bn
3,5-(MeO)2C6H3
4-t-BuC6H4
4-EtC6H4
g
h
i
(7) For studies from our laboratory, see: (a) Dang, T. T.; Dang,
T. T.; Ahmad, R.; Reinke, H.; Langer, P. Tetrahedron Lett.
2008, 49, 1698. (b) Dang, T. T.; Villinger, A.; Langer, P.
Adv. Synth. Catal. 2008, 350, 2109. (c) Hussain, M.;
Nguyen, T. H.; Langer, P. Tetrahedron Lett. 2009, 50, 3929.
(d) Tengho Toguem, S.-M.; Hussain, M.; Malik, I.;
Villinger, A.; Langer, P. Tetrahedron Lett. 2009, 50, 4962.
(e) Dang, T. T.; Dang, T. T.; Rasool, N.; Villinger, A.;
Langer, P. Adv. Synth. Catal. 2009, 351, 1595.
3,5-Me2C6H3
4-ClC6H4
j
g
a Yields of isolated compounds.
Acknowledgment
(8) Iddon, B.; Toender, J. E.; Hosseini, M.; Begtrup, M.
Tetrahedron 2007, 63, 56.
Financial support from the State of Pakistan (HEC scholarship for
M.H.), from the DAAD (scholarships for A.A. and R.A.K.), from
the State of Mecklenburg-Vorpommern (scholarships for M.H. and
J.T.), and from the Friedrich-Irmgard-Harms-Stiftung (scholarship
for A.A.) is gratefully acknowledged. Partial financial support by
the Ministry of Science of the Republic of Serbia, Grant No.
142007, is gratefully acknowledged.
(9) For pharmacologically relevant 3,4,5-triarylpyrazoles, see:
(a) Meanwell, N. A.; Rosenfeld, M. J.; Wright, J. J. K.;
Brassard, C. L.; Buchanan, J. O. J. Med. Chem. 1992, 35,
389. For pharmacological relevant 3,5-diaryl-4-bromo-
pyrazoles, see: (b) Bondavalli, F.; Bruno, O.; Ranise, A.;
Schenone, P.; Donnoli, D. Farmaco 1989, 44, 655.
(c) Bondavalli, F.; Bruno, O.; Ranise, A.; Schenone, P.;
Addonizio, P. Farmaco 1988, 43, 725. Only very few
5-aryl-3,4-dibromopyrazoles have been reported so far:
(d) Trofimenko, S.; Yap, G. P. A.; Jove, F. A.; Claramunt,
R. M.; Garcia, M. A.; Santa Maria, M. D.; Alkorta, I.;
Elguero, J. Tetrahedron 2007, 63, 8104.
References and Notes
(1) (a) van Herk, T.; Brussee, J.; van den Nieuwendijk,
A. M. C. H.; van der Klein, P. A. M.; Ijzerman, A. P.;
Stannek, C.; Burmeister, A.; Lorenzen, A. J. Med. Chem.
2003, 46, 3945. (b) Varano, F.; Catarzi, D.; Colotta, V.;
Filacchioni, G.; Galli, A.; Costagli, C.; Carlà, V. J. Med.
Chem. 2002, 45, 1035. (c) Clayden, J.; Geeves, N.; Warren,
S. Organic Chemistry; Oxford University Press: Oxford,
2000. (d) Dannhardt, G.; Laufer, S. Curr. Med. Chem. 2000,
71101. (e) Carty, T. J.; Marfat, A. Curr. Opin. Anti-Inflamm.
Immunomod. Invest. Drugs 1999, 1, 89. (f) Nicolaou, K. C.;
Pratt, B. A.; Arseniyadis, S.; Wartmann, M.; O’Brate, A.;
Giannakakou, P. ChemMedChem 2006, 1, 41.
(2) (a) The Chemistry of Heterocyclic Compounds, Part 1, Vol.
49; Grunanger, P.; Vita-Finzi, P., Eds.; John Wiley: New
York, 1991. (b) Aggarwal, V. K.; de Vincente, J.; Bonnert,
R. V. J. Org. Chem. 2003, 68, 5381. (c) Deng, X.; Mani,
N. S. Org. Lett. 2006, 8, 3505.
(3) (a) Handbook of Heterocyclic Chemistry; Katritzky, A. R.;
Pozharskii, A. F., Eds.; Pergamon: Oxford, 2000.
(b) Heller, S. T.; Natarajan, S. R. Org. Lett. 2006, 8, 2675.
(c) Humphries, P. A.; Finefield, J. M. Tetrahedron Lett.
2006, 47, 2443. (d) Bishop, B. C. Synthesis 2004, 43.
(e) Ahmed, S. M.; Kobayashi, K.; Mori, A. Org. Lett. 2005,
7, 4487.
(10) Grandberg, A. J. Gen. Chem. USSR (Engl. Transl.) 1963, 33,
503; Zh. Obshch. Khim. 1963, 33, 511.
(11) General Procedure for Suzuki–Miyaura Coupling
Reactions
To a 1,4-dioxane solution (4 mL) of 2a,b (152 mg, 0.5
mmol) was added Pd(PPh3)4 (3–10 mol%) at 20 °C under
argon atmosphere. After stirring for 30 min, the arylboronic
acid (1.0–1.2 equiv per bromine atom of the substrate),
K3PO4 (1.5 equiv per bromine atom of the substrate), and
H2O (1.0 mL) were added. The mixture was heated for 12 h
at 100 °C. After cooling to 20 °C, the mixture was diluted
with H2O, extracted with CH2Cl2 (3 × 25 mL), dried
(Na2SO4), and filtered. The solvent of the filtrate was
concentrated in vacuo and the residue was purified by
column chromatography (heptanes–EtOAc).
(12) 3,4-Dibromo-5-(4-methoxyphenyl)-1-vinyl-1H-pyrazole
(4c)
Starting with 2b (165 mg, 0.50 mmol), Pd(PPh3)4 (18 mg, 3
mol%), 1,4-dioxane–H2O (4:1, 5 mL), K3PO4 (159 mg, 0.75
mmol), and 4-methoxyphenylboronic acid (76 mg, 0.50
mmol), 4c was isolated as a white solid (131 mg, 73%). 1H
Synlett 2010, No. 13, 1923–1926 © Thieme Stuttgart · New York